Report from the Annual General Meeting in AQILION AB
Helsingborg, Sweden – June 18, 2021 – AQILION AB (publ) held its Annual General Meeting today on June 18, 2021, during which the Meeting resolved in accordance with the proposals set forth by the…
News
Aqilion publishes the Annual Report for 2020
AQILION AB (publ) announces hereby that the Swedish version of the 2020 Annual Report has been published and is available on the company’s website. The 2020 Annual Report in Swedish can be…
Aqilion strengthens the company’s Alnitak pharmaceutical project in chronic inflammation through closer collaboration with Örebro University researchers
Aqilion announced today that the company has initiated an expanded collaborative effort with Professor Eva Särndahl and Senior Lecturer Alexander Persson at the School of Medical Sciences, Örebro…
Aqilion strengthens its operational team in line with the company’s research strategy
Aqilion announced today that Johan Lund, the current Chairman of the company, will join the operational team as Chief Scientific Officer beginning on March 1. Johan Lund will mainly contribute his…